Ronald Dixon

Ronald Dixon is the current Chief Medical Officer at Remedy. Ronald was previously the President & CEO of Onduo, LLC from January 2018 to July 2020. Onduo is a joint venture between Verily (Google) and Sanofi that uses cutting-edge technology, big data, and deep healthcare expertise to help people living with diabetes live their best life.

Dixon was responsible for leading all clinical practice functions at Onduo, including physicians, midlevels and coaches. Ronald also led certification processes for Onduo's telemedicine practices, clinical performance reporting, outcome measurement and improvement, and the development of evidence regarding Onduo's clinical and financial efficacy. Ronald negotiated performance aspects of value based contracts with insurers and employers, and represented the clinical division during all aspects of sales from opening to closing. Ronald also represented clinical interests during the iterative software product development cycle.

Ronald Dixon's educational career includes obtaining a Doctor of Medicine from Dartmouth College, a Master's degree in Clinical Neuropsychology from University at Buffalo, and a Bachelor of Science in Biology-Psychology from McGill University.

Some of their coworkers include Tabatha Erck - COO, Keith Munro - CMO, and Liz Ketter - CFO. Ronald Dixon reports to Jeremy Gabrysch, CEO.